Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
Results were presented at the ASCO annual meeting in Chicago, which attracts over 40,000 cancer specialists.
The trial was treating patients with joint pain or joint stiffness.
The new CEO’s mandate is to accelerate partnering discussions and explore opportunities to fully exploit the midkine assets.
Doctors can administer the treatment to patients under the TGA Special Access Scheme.
The company finished the March quarter with $21 million in the bank.
The company’s Onco-PDO cancer screening service supports personalised clinical decisions for patients.
The company has today commenced the retail component of its $77.9 million capital raising.
Dr. Lesley Russell brings extensive pharmaceutical experience to the board including a number of cancer therapy collaborations with Teva Pharmaceuticals.